Alberto A Arteaga

Physician Resident

MD, Department of Otolaryngology Head and Neck Surgery, University of Mississippi Medical Center, USA.

Latest Contribution

Graph showing mild therapeutic hypothermia and cisplatin-induced hearing loss.

COOL therapy for cisplatin-induced hearing loss

5 July 2022 | | ENTA-Audiology - Adult, ENTA-Audiology - Paediatric

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...